PTCT PTC THERAPEUTICS, INC.
Price Chart
Executive Summary
Three corporate insiders at PTC Therapeutics sold shares in a coordinated 7-day window, including the Chief Medical Officer and Chief Technical Operations Officer, totaling $1.29 million in open-market transactions. The sales represent a modest but notable insider selling cluster, with executives and a director reducing holdings at current market prices.
Key Financial Metrics
Actionable Insight
Monitor for potential follow-up selling or commentary ahead of next earnings; coordinated C-suite exits may signal caution despite no public negative news. Compare with historical patterns — if this deviates from routine selling, it could foreshadow downside risk.
Key Facts
- EVP & Chief Medical Officer Scott Golden sold 10,000 shares for $633,800 in an open-market transaction.
- Director Stephanie Okey sold 6,333 shares for $401,385.54 in an open-market transaction.
- Chief Technical Operations Officer Neil Almstead sold 3,989 shares for $252,822.82 in an open-market transaction.
- All transactions occurred on 2026-03-05 at $63.38 per share, totaling $1.288 million in aggregate.
- Total value of the cluster is approximately 0.025% of the company's $5.2B market cap — modest in scale but notable due to participation by C-suite executives.
Financial Impact
$1.288 million in insider selling, representing 0.025% of market capitalization
Risk Factors
- Perception of insider lack of confidence, especially with Chief Medical Officer selling.
- Potential for negative sentiment amplification if no fundamental explanation is provided.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-PTCT-1773091238112 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 9, 2026
3d ago
|
8-K
| $73.75 awaiting T+5 | awaiting T+5 | — | $75.14 (+1.88%) |
|
May 19, 2026
24d ago
|
Insider Cluster
| $71.02 $71.05 | ▲ +0.04% | ▼ −1.76% | $75.14 (+5.80%) |
|
May 15, 2026
28d ago
|
Insider Cluster
| $70.15 $67.65 | ▼ −3.56% | ▼ −5.18% | $75.14 (+7.11%) |
|
Apr 28, 2026
6w ago
|
8-K
| $64.55 $66.57 | ▲ +3.13% | ▲ +0.02% | $75.14 (+16.41%) |
|
Apr 20, 2026
7w ago
|
DEFA14A
| $70.63 $70.26 | ▼ −0.52% | ▼ −1.61% | $75.14 (+6.39%) |
|
Apr 1, 2026
10w ago
|
Insider Cluster
| $68.75 $70.85 | ▼ −3.05% | ▲ +0.71% | $75.14 (−9.29%) |
|
Mar 5, 2026
14w ago
|
Insider Cluster
| $63.33 $63.36 | ▲ +0.05% | ▲ +2.29% | $75.14 (+18.65%) |
|
Mar 5, 2026
14w ago
|
Insider Cluster
| $63.33 $63.36 | ▼ −0.05% | ▼ −2.29% | $75.14 (−18.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access